Skip to main content

Table 2 Post-translational modifications (PTMs) of 18 isoforms of cerebrospinal fluid alpha-1-antitrypsin

From: Do fragments and glycosylated isoforms of alpha-1-antitrypsin in CSF mirror spinal pathophysiological mechanisms in chronic peripheral neuropathic pain? An exploratory, discovery phase study

SPOT NUMBER

Mw (kDa)

pI

Unique peptides

Peptides position START-END

PTM

1605

153.0

5.50

18

35–418

N-glycosylation

1606

153.0

5.52

18

35–418

N-glycosylation

2601

153.0

5.54

18

35–418

N-glycosylation

1310

70.9

5.25

14

35–418

1308

69.5

5.35

20

35–418

2311

69.5

5.39

25

35–418

2310

68.2

5.44

25

35–418

2308

68.2

5.50

31

35–418

216

36.7

4.78

6

180–411

N-terminal truncation

215

35.4

4.80

16

126–418

N-terminal truncation

214

33.4

4.90

6

35–241

C-terminal truncation

111

38.9

5.10

10

126–418

N-terminal truncation

110

37.4

5.15

16

154–418

N-terminal truncation

5106

19.4

6.50

7

299–418

N-terminal truncation

1505

57.6

5.3

12

35–418

N-glycosylation

2504

60.9

5.5

12

35–418

N-glycosylation

2508

68.3

5.5

12

35–418

N-glycosylation

2512

68.2

5.4

12

35–418

N-glycosylation